Intelligence Briefs — The AI Act Value Gap

MB AI's reference document: why regulatory risk creates a valuation gap on AI assets, and how the D7™ rating closes it.

Bain: 1 in 5 acquirers abandoned an AI deal in 2026. Regulatory risk doesn't kill the deal — it discounts it. Verified tier-1 sources (consulting, M&A, audit).

Regulatory risk attaches to the asset and survives closing. Verizon paid $350M for it on Yahoo. The AI Act is replaying the script.

Brown Rudnick: compliance is the golden ticket to exit; noncompliance, a market access barrier. Just as SOC 2 was for SaaS.

Insurers are excluding AI representations. An unscored asset becomes partially uninsurable — and therefore discounted. The score makes it coverable.

The one major signature linking the AI Act and valuation by name. It's no longer your argument — it's theirs.

The regulator faulted the due diligence. The liability survives closing. The AI Act opens the same trap.

AI risk already has its line in the contract — a holdback that freezes your price for two years. The score reduces it.

Off the balance sheet, written into the law, attached to the asset. It changes owner at closing.

A landmark study covered the AI Act in private equity. Ten AI holdings = ten exposures. MB Shield Portfolio monitors them.

Annex III targets entire markets. That's where regulatory risk — and therefore the discount — concentrates.

10²⁵ FLOPs threshold, systemic risk, copyright, adversarial evaluation. The acquirer inherits it — obligations in force since August 2025.

Capgemini describes it as a readiness to maintain. The Digital Omnibus proved it: the law moves. An attestation expires — MB Shield maintains it.